News Articles

      • 15 February, 2018

    ISSCR Releases Guidebook to Evaluate Cell Therapy Trials

    The ISSCR is pleased to announce the release of “Stem Cell Based Clinical Trials: Practical Advice for Physicians and Ethics / Institutional Review Boards,“ a guidebook providing background and fundamental questions for clinicians and review boards to ask when considering running or reviewing early phase, cell-based clinical trials. The guide was developed by practicing physician-scientists and stem cell professionals on the ISSCR’s Clinical Translation Committee.
    Full story
      • 9 February, 2018

    Showcasing Inspiring Science and Natural Beauty

    There is no better host city for the ISSCR 2018 annual meeting than Melbourne, Australia, a global hub of innovation in science and biotech with a rich stem cell history, flourishing research culture, and inspiring natural beauty and art.
    Full story
      • 7 February, 2018

    Stem Cell Reports Seeking Editor-in-Chief

    The ISSCR’s official journal, Stem Cell Reports, is seeking applications for a new Editor-in-Chief to succeed Christine Mummery, who has served in that role since the journal's inception in 2012.
    Full story
      • 17 January, 2018

    ISSCR Members Asked to Vote for Future Leaders

    The election is open for several ISSCR leadership posts, and members and trainee members are eligible to cast ballots in the election. Voting closes 5 February, 2018.
    Full story
      • 9 January, 2018

    ISSCR 2018: Stem Cells Down Under

    Stem cell research has led to profound insights into how developmental processes work in plants, animals, and humans. Increasingly, our work has shed light on how different life forms begin, develop, mature, and respond to injury and age. Myriad advances continue to contribute to understanding biology, cell function, disease and its treatment, senescence, and end of life.
    Full story
      • 4 January, 2018

    ISSCR Announces Two New Science Communications & Education Managers

    The ISSCR has selected Christopher Barry, PhD, and Julie Perlin, PhD, to be Science Communications & Education Managers, beginning 3 January, 2018.
    Full story
      • 4 January, 2018

    ISSCR Remembers Hiromitsu “Hiro” Ogawa

    The ISSCR is saddened by the passing of Hiromitsu “Hiro” Ogawa, a generous and thoughtful man who was a great supporter of stem cell science and the ISSCR.
    Full story
      • 11 December, 2017

    ISSCR Announces New Policy Director, Eric Anthony

    The ISSCR has named Eric Anthony to be its new Director of Policy. Anthony served more than eight years as staff in the U.S. Congress, most recently as legislative director for Congresswoman Rosa DeLauro of Connecticut. He will join the Society in early January 2018.
    Full story
      • 8 December, 2017

    The ISSCR Remembers Ihor Lemischka

    The ISSCR joins the stem cell community in expressing sadness at the passing of Ihor Lemischka, PhD, Professor of Developmental and Regenerative Biology, Pharmacology and Systems Therapeutics at the Icahn School of Medicine.
    Full story
      • 6 December, 2017

    Message from the President: 2017 Year in Review

    The ISSCR celebrated its 15th year as a global voice for stem cell research, and our efforts and activities in 2017 reflect the key role the society plays in advancing the field. We advocated on behalf of members in the policy and regulatory arenas, provided resources for the public, and continued to provide a global forum for scientists to gather and share research.
    Full story
      • 6 December, 2017

    Registration, Abstract Submissions Open for ISSCR 2018

    The ISSCR annual meeting is the world’s largest gathering of stem cell scientists, and in 2018 the meeting will be held in Melbourne, AU, 20-23 June, at the Melbourne Convention & Exhibition Centre. The meeting brings together some 3500 stem cell researchers and clinicians from around the world to share the latest developments in stem cell research and regenerative medicine.
    Full story
      • 17 November, 2017

    ISSCR Applauds the FDA Announcement of New Guidelines for Cellular Therapies and Cell-based Tissue Products

    The ISSCR commends the U.S. Food and Drug Administration (FDA) for reaffirming its regulatory authority over stem cell biologics and clarifying the criteria that determine which cell-based products fall under its oversight. These guidance documents will provide greater transparency for patients, medical professionals, and law enforcement authorities, about the legal status of stem cell treatments in the U.S.
    Full story
      • 10 October, 2017

    Celebrating Stem Cell Awareness Day, 11 October, 2017

    Each year, Stem Cell Awareness Day is an opportunity to reflect on the scientific advances and discoveries that are rapidly moving the field forward, with implications for the future of regenerative medicine and human health.
    Full story
      • 5 October, 2017

    ISSCR President Writes in Support of Fetal Tissue Research

    In an opinion editorial published today, the president of the ISSCR, Hans Clevers, underscores the importance of fetal tissue research. “Fetal tissue has been essential in research used to develop therapies that have saved millions of lives, and it continues to be necessary for the future of medicine,” he writes.
    Full story
      • 4 October, 2017

    ISSCR Applauds California Bill to Assist Stem Cell Patients

    A measure signed into law 3 October in the state of California, U.S., requires clinics to inform patients if they are using stem cell interventions that have not been approved by the Food and Drug Administration (FDA). ISSCR president Hans Clevers expresses support for the measure.
    Full story